Novo Nordisk A/S (LON:0QIU)
349.54
+4.74 (1.37%)
At close: Sep 12, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 179.31 billion as of September 15, 2025. Its market cap has decreased by -60.45% in one year.
Market Cap
179.31B
Enterprise Value
188.62B
Revenue
35.84B
Ranking
n/a
PE Ratio
14.05
Stock Price
349.54
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 4.46B to 179.31B, an increase of 3,920.03%. That is a compound annual growth rate of 13.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 179.31B | -41.84% |
Dec 30, 2024 | 308.32B | -14.91% |
Dec 29, 2023 | 362.35B | 43.42% |
Dec 30, 2022 | 252.66B | 33.68% |
Dec 30, 2021 | 189.00B | 57.73% |
Dec 30, 2020 | 119.83B | 15.27% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 182.89B |
HSBC Holdings | 173.69B |
Shell | 153.74B |
Unilever | 115.27B |
Rolls-Royce Holdings | 94.89B |
British American Tobacco p.l.c. | 90.78B |
Rio Tinto Group | 78.69B |
BP p.l.c. | 64.96B |